F26-068019Grade B: PossibleOpen
SlovakiaOpen tenderKind of contract: Goods
Slovakia – Antineoplastic and immunomodulating agents – Antineoplastic and immunomodulating agents
Original: Slovakia – Antineoplastic and immunomodulating agents – Antineoplastické a imunomodulačné činidláMachine translation- Buyer
- Fakultná nemocnica s poliklinikou Žilina · Slovakia
- Posted
- 9 October 2026
- Deadline
- 9 November 2026
- Reference number
- 699237-2026
- CPV codes
- 33652000
- Place of delivery
- SK031 (Slovakia); Žilina, Slovakia
In short
- Wanted: Chemicals & cosmetics.
- Estimated value: €947,649, as the notice states it.
- Buyer: Fakultná nemocnica s poliklinikou Žilina, Slovakia.
- Offers by 9 November 2026, 3 days left.
Can a company from Türkiye take part?
The buyer decides on Turkish bids
- Türkiye has no procurement agreement with this market: a Turkish firm has no right of access, but the buyer may accept its bid.
Rests on: Directive 2014/24/EU, Art. 25; Court of Justice, C-652/22 Kolin (22 October 2024)
Guidance from the official rules, not legal advice: the tender documents decide.
Next step
Within the week: download the notice and its documents now, and complete what you are missing.
If taking part directly is unclear, go in with a partner or distributor in that country.
Documents to prepare
- The selection criteria are set out in the procurement documents.
- Offers are made electronically.
- Offers in: Slovak.
Read from the notice's own codes, not its text.
The full list of what to submit is in the tender documents at the source.
Grade B: PossibleWhy this grade?
- Whether to accept a Turkish bid is up to the buyer
- A purchase of goods: can be supplied from Türkiye
- Türkiye is strong in this product group: €1.6B exported in 2025
- No Turkish supplier found that fits yet
Türkiye's exports: Eurostat, Comext DS-059341 (2025); the ranking is Birlesa's.
How do I apply?
- Read the notice at its source: its conditions and documents are written there.
- Prepare the documents below.
- Submit your offer before the deadline: 9 November 2026.
- When taking part directly is not certain, applying with a partner in the buyer's country helps.
Items
| Item | Quantity |
|---|---|
| Slovakia – Antineoplastic and immunomodulating agents – Antineoplastické a imunomodulačné činidlá Antineoplastické a imunomodulačné činidlá pre potreby FNsP. Antineoplastické a imunomodulačné činidlá: Trastuzumab sol inj 1x5 ml/600 mg 200 Pertuzumab con inf 1x420 mg 75 Trastuzumab-emtanzín plc ifc 1x100 mg 115 Trastuzumab-emtanzín plc ifc 1x160 mg 25 Pertuzumab and trastuzumab sol inj 1x15 ml/1200 mg/600 mg 10 Pertuzumab and trastuzumab sol inj 1x10 ml/600 mg/600 mg 185 Bevacizumab con inf 1x4 ml/100 mg 75 neregistrovaná očná indikácia | — |
Show the codes
- 1. cpv:33652000, nace:21, nace:21.2
History
- First seen by Birlesa: 2026-10-27T17:55:40.811338Z
Changes are recorded since 5 November 2026. Nothing has changed since then.